IRIS
IACOBELLI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.595
AS - Asia 2.615
EU - Europa 1.752
SA - Sud America 398
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 22.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.537
SG - Singapore 1.183
CN - Cina 413
BR - Brasile 326
RU - Federazione Russa 319
KR - Corea 282
HK - Hong Kong 270
IT - Italia 218
UA - Ucraina 202
SE - Svezia 178
DE - Germania 164
IE - Irlanda 162
FI - Finlandia 155
VN - Vietnam 155
GB - Regno Unito 120
FR - Francia 94
JP - Giappone 73
ID - Indonesia 48
IN - India 41
CA - Canada 34
CZ - Repubblica Ceca 34
NL - Olanda 27
AR - Argentina 26
AT - Austria 22
IQ - Iraq 19
CO - Colombia 18
TR - Turchia 15
BD - Bangladesh 14
PH - Filippine 13
PK - Pakistan 13
PL - Polonia 13
GH - Ghana 12
IR - Iran 12
ZA - Sudafrica 12
BE - Belgio 11
CL - Cile 11
ES - Italia 11
MX - Messico 11
JO - Giordania 10
EU - Europa 8
MA - Marocco 8
SA - Arabia Saudita 8
AU - Australia 7
AZ - Azerbaigian 6
DZ - Algeria 6
NP - Nepal 6
UZ - Uzbekistan 6
CR - Costa Rica 5
GR - Grecia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
EG - Egitto 4
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
MY - Malesia 4
NO - Norvegia 4
UY - Uruguay 4
VE - Venezuela 4
IL - Israele 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
IS - Islanda 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
PS - Palestinian Territory 1
SN - Senegal 1
SO - Somalia 1
TG - Togo 1
TJ - Tagikistan 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 22.430
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.563
Wilmington 4.295
Houston 3.960
Fairfield 656
Singapore 587
Ashburn 441
Ann Arbor 385
Seattle 277
San Jose 274
Chandler 271
Hong Kong 264
Cambridge 245
Creede 202
Dublin 155
Santa Clara 153
Jacksonville 144
Medford 135
Beijing 104
Helsinki 96
Rome 79
The Dalles 75
Moscow 64
Council Bluffs 61
Lawrence 60
Lauterbourg 59
Dearborn 57
New York 57
Los Angeles 52
Ho Chi Minh City 51
Tokyo 51
Buffalo 49
Zhengzhou 42
Nanjing 38
Hanoi 37
Jakarta 37
Milan 31
San Diego 31
Brno 29
London 29
Redwood City 26
Shanghai 26
Nuremberg 25
São Paulo 24
Philadelphia 23
Scottsdale 20
Petaluma 18
Dallas 15
North Bergen 15
Redondo Beach 15
Chicago 14
Rio de Janeiro 13
Toronto 13
Accra 12
Belo Horizonte 12
Chennai 12
Seoul 12
Brussels 11
Mülheim 11
Orem 11
Warsaw 11
Norwalk 10
Amman 9
Baghdad 9
Turku 9
Atlanta 8
Bogotá 8
Brasília 8
Brooklyn 8
Lappeenranta 8
Manila 8
Phoenix 8
Stockholm 8
Amsterdam 7
Boardman 7
Haiphong 7
Hangzhou 7
Kilburn 7
Munich 7
Nanchang 7
Naples 7
Pereira 7
Roppongi 7
Vienna 7
Wuhan 7
Denver 6
Guangzhou 6
Hefei 6
Johannesburg 6
Kunming 6
Las Vegas 6
Manchester 6
Washington 6
Baku 5
Center 5
Da Nang 5
Frankfurt am Main 5
Geumcheon-gu 5
Groningen 5
Haeundae-gu 5
Montreal 5
Totale 18.808
Salva come PNG Salva come JPEG
Nome #
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial) 665
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT) 538
Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation 503
M4 acute myeloid leukemia: the role of eosinophilia and cytogenetics in treatment response and survival. The GIMEMA experience. 468
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study 465
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study 457
Salvage use of allogeneic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the EBMT Chronic Malignancies Working Party 450
Efficacy and outcome of autologous transplantation in rare myelomas 434
Superiority of the Triple Combination of Bortezomib-Thalidomide-Dexamethasone Over the Dual Combination of Thalidomide-Dexamethasone in Patients With Multiple Myeloma Progressing or Relapsing After Autologous Transplantation: The MMVAR/IFM 2005-04 Randomized Phase III Trial From the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation 433
Multiple time scales in multi-state models 431
Outcome of patients developing GvHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT 428
Assessment of the role of timing of second transplantation in multiple myeloma by multistate modeling 427
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT. 427
Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease? 427
Comparison of Intensive Chemotherapy and Hypomethylating Agents before Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndromes: A Study of the Myelodysplastic Syndrome Subcommittee of the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplant Research 427
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia 426
Partially anaortic clampless off-pump coronary artery bypass prevents neurologic injury compared to on-pump coronary surgery: a propensity score-matched study on 286 patients 420
Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party 420
Tandem autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in myeloma: long-term follow-up 419
Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia 418
Stem cell transplantation for chronic myeloid leukemia in children 417
Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation 414
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia 412
Protective Environment for Hematopoietic Cell Transplant (HSCT) Recipients: The Infectious Diseases Working Party EBMT Analysis of Global Recommendations on Health-Care Facilities 411
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group 408
Current practices used for the prevention of central venous catheter-associated infection in hematopoietic stem cell transplantation recipients: a survey from the Infectious Diseases Working Party and Nurses' Group of EBMT 407
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation 402
Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties 399
Low tumor burden is associated with early B-cell reconstitution and is a predictor of favorable outcome after non-myeloablative stem cell transplant for chronic lymphocytic leukemia 396
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation 394
Autologous/reduced-intensity allogeneic stem cell transplantation versus autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study 393
Efficacy and outcome of allogeneic transplantation in IgD and nonsecretory myeloma. A report on behalf of the Myeloma Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation 391
Survival probabilities with time-dependent treatment indicator: quantities and non-parametric estimators 383
The Cox shared frailty model with log-skew-normal frailties 380
Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation 378
Length of stay in different drug using states: lifestyles of problem and recreational drug consumers 377
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the chronic malignancies working party of the EBMT 377
Allogenic hematopoietic stem cell transplantation in patients with polycythemia or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: report from the MPN subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation 372
Melphalan 140mg/M2 Or 200mg/M2 For Autologous Transplantation In Myeloma: Results From The Collaboration To Collect Autologous Transplant Outcomes In Lymphoma And Myeloma (CALM) Study. A Report By The EBMT Chronic Malignancies Working Party 371
Incidence of Second Primary Malignancies after Autologous Transplantion for Multiple Myeloma in the Era of Novel Agents. 370
Primary plasma cell leukemia and autologous stem cell transplantation 366
Evaluation of short- and long-term response to treatment in GIMEMA protocol for Acute Myeloid Leukaemia 353
Impact of complete remission before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial 352
Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation. 339
Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion 336
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma. 327
Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma 316
Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita 266
Allogeneic transplantation in multiple myeloma - Does it still have a place? 155
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL) 150
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy 132
Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT) 105
Pollen variability in Quercus L. species and relative systematic implications 102
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modelling 97
Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP 96
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors 87
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT 86
Analyzing differences between restricted mean survival time curves using pseudo-values 86
Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation 85
Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation 84
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced-intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT 82
Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes 81
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT 81
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation 80
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT 78
Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor 78
Impact of T-cell depletion strategies on outcomes following hematopoietic stem cell transplantation for idiopathic aplastic anemia: a study on behalf of the European blood and marrow transplant severe aplastic anemia working party. 78
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia 78
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101 77
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT 75
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study 73
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation 71
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study 70
Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation 69
Intercontinental study on pre-engraftment and post-engraftment Gram-negative rods bacteremia in hematopoietic stem cell transplantation patients: risk factors and association with mortality 67
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma 65
Impact of donor-derived CD34+infused cell dose on outcomes of patients undergoing allo-HCT following reduced intensity regimen for myelofibrosis: a study from the Chronic Malignancies Working Party of the EBMT 63
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP 61
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia 61
Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia 60
Benefit and timing of second transplantations in multiple myeloma: clinical findings and methodological limitations in a European Group for Blood and Marrow Transplantation registry study 57
Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation 54
ZAP-70 expression in acute lymphoblastic leukemia: association with the E2A/PBX1 rearrangement and the pre-B stage of differentiation and prognostic implications 54
Outcomes and toxicity of allogeneic HCT in CML patients previously treated with second generation TKIs: a prospective non-interventional study from the Chronic Malignancy Working Party of EBMT 54
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma 53
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison 51
Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors 51
The effect of prior exposure to imatinib on transplant-related mortality 51
Role of stem cell transplantation in myeloma 46
Statistical methods in HSCT and cellular therapies 45
Reduced-intensity conditioning for myeloma: lower nonrelapse mortality but higher relapse rates compared with myeloablative conditioning 43
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants 35
Totale 22.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.718
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.718
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 0 0 0 0 96 121 29
2021/2022768 41 85 84 52 21 51 43 26 34 55 57 219
2022/20231.379 88 77 40 77 76 205 411 229 78 18 44 36
2023/2024386 34 18 29 28 45 54 34 22 32 28 8 54
2024/20251.762 50 399 184 110 15 172 114 66 189 174 129 160
2025/20262.628 197 210 362 156 172 126 373 407 393 232 0 0
Totale 22.897